Fig. 2From: Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camelsAntibody titres of camels vaccinated with a live CL13T RVF vaccine tested by VN and cELISA. Neutralizing antibody were tested in all vaccinated camels by VN and cELISA test, a significant differences (p < 0.05) in antibody titers were observedBack to article page